Related Experiment Video
Updated: Nov 5, 2025

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
Astragalus polysaccharide protects formaldehyde-induced toxicity by promoting NER pathway in bone marrow mesenchymal
Yali She1,2, Xiaowen Zhao1, Pingfan Wu1
1Department of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Introduction:
In our previous study, it has been confirmed that formaldehyde (FA) not only inhibits the proliferative activity, but also causes DNA-protein crosslinks (DPCs) formation in bone marrow mesenchymal stem cells (BMSCs). The purpose of this study was to detect the protective effect of astragalus polysaccharide (APS) against the cytotoxicity and genotoxicity of BMSCs exposed to FA, and to explore potential molecular mechanisms of APS activity.
Material And Methods:
Human BMSCs were cultured in vitro and randomly divided into control cells (Ctrl group), FA-treated cells (FA group, 120 μmol/L), and cells incubated with FA and increasing concentrations (40, 100, or 400 μg/mL) of APS (FA + APS groups). Cytotoxicity was measured by MTT assay. DNA strand breakage, DNA-protein crosslinks (DPCs), and micronucleus formation were respectively detected by comet assay, KCl-SDS precipitation assay, and micronucleus assay. The mRNA and protein expression level of xeroderma pigmentosum group A (XPA), xeroderma pigmentosum group C (XPC), excision repair cross-complementation group 1 (ERCC1), replication protein A1 (RPA1), and replication protein A2 (RPA2) were all detected by qRT-PCR and Western Blot.
Results:
Compared with the FA group, the cytotoxicity, DNA strand breakage, DPCs, and micronucleus levels were decreased significantly in FA + APS groups (P < 0.01). Meanwhile, the mRNA and protein expression of XPA, XPC, ERCC1, RPA1, and RPA2 were up regulated significantly in the FA + APS groups (P < 0.05) with the most prominent effect of the 100 μg/mL APS.
Conclusions:
Our results suggest that APS can protect the cytotoxicity and genotoxicity of human BMSCs induced by FA. The mechanism may be associated with up-regulated expression of XPA, XPC, ERCC1, RPA1, and RPA2 in the nucleotide excision repair (NER) pathway which promotes DNA damage repair.
Insights
Astragalus polysaccharide (APS) protects bone marrow mesenchymal stem cells (BMSCs) from formaldehyde (FA) damage. APS reduces cytotoxicity and DNA damage by enhancing DNA repair gene expression.
Area of Science:
- Biomedical Science
- Cell Biology
- Toxicology
Background:
- Formaldehyde (FA) induces cytotoxicity and DNA-protein crosslinks (DPCs) in bone marrow mesenchymal stem cells (BMSCs).
- Previous studies confirmed FA's inhibitory effects on BMSC proliferation and its genotoxicity.
Purpose of the Study:
- To evaluate the protective effects of astragalus polysaccharide (APS) against FA-induced cytotoxicity and genotoxicity in BMSCs.
- To investigate the molecular mechanisms underlying APS's protective activity.
Main Methods:
- Human BMSCs were exposed to FA and varying concentrations of APS.
- Cytotoxicity assessed via MTT assay; DNA damage measured by comet assay, KCl-SDS precipitation assay, and micronucleus assay.
- Expression of DNA repair genes (XPA, XPC, ERCC1, RPA1, RPA2) analyzed using qRT-PCR and Western Blot.
Main Results:
- APS significantly reduced FA-induced cytotoxicity, DNA strand breaks, DPCs, and micronucleus formation.
- mRNA and protein levels of XPA, XPC, ERCC1, RPA1, and RPA2 were significantly upregulated in APS-treated groups.
- The 100 μg/mL APS concentration showed the most prominent protective effect.
Conclusions:
- APS demonstrates significant protective effects against FA-induced cytotoxicity and genotoxicity in human BMSCs.
- The mechanism involves the upregulation of nucleotide excision repair (NER) pathway genes, promoting DNA damage repair.
More Related Videos
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015